Ed Lascelles, Partner at Albion VC chats to Maddyness, a magazine for entrepreneurs, about investing in tech, the importance of company culture, emerging trends and much more.

Read more

AlbionVC exits Clear Review after a strategic acquisition by Advanced. AlbionVC led Clear Review's Series A investment in 2019 and today is pleased to see the company embark on the next stage of growth.

Read more

Christoph Ruedig, AlbionVC Partner reflects on how technology is driving innovation and change within clinical trials. 

Read more

Elliptic, Quantexa and Speechmatics named among the 25 fastest growing technology businesses in the UK. 

Read more

AlbionVC has secured 3 nominations in GP. Bullhound Investor Allstars 2020 for venture capital fund of the year, exit of the year and Ed Lascelles, Partner at AlbionVC as investor of the year. 

Read more

Odin Vision, a UCL Technology Fund portfolio company has received a grant to accelerate its cutting edge AI technology to fight bowel cancer. Odin Vision’s technology assists doctors to detect and characterise cancerous and pre-cancerous polyps during colonoscopy procedures.

Read more

Jay Wilson, Investment Manager at AlbionVC reflects on the impact of Covid-19 on M&A activity in fintech and discusses how his view has changed from the start of the pandemic to now. More on the story in FintechFutures.  

Read more

Quantexa, the Contextual Decision Intelligence and financial data analytics company is ranked No.14 on The Sunday Times Tech Track 100.  

Read more